The ACMG Foundation is guided by a distinguished group of leaders who are recognized for their expertise and commitment to advancing medical genetics and genomics. Through their leadership and philanthropy, they help create opportunities that strengthen the genetics workforce, support education and research, and improve the lives of patients and families. Together, they are committed to Empowering ACMG Through Giving by investing in the people, programs, and initiatives that advance the future of genetics and genomics.

ACMGF Board of Directors

The Board of Directors is responsible for the direction and completion of ongoing work of the organization defined by the ACMGF’s mission statement and strategic plan. ACMGF Board members are volunteers and elected by colleagues. Once approved, a member is eligible to serve a term commencing at the ACMG Annual Meeting. Responsibilities include, but are not limited to: fundraising and fiduciary governance, oversight of legal and ethical considerations, and strategic direction.

Brynn Levy, MSc(Med), PhD, FACMG

President

2026 – 2028

Nancy J. Mendelsohn, MD, FACMG

Past President

2026 – 2028

Harry Ostrer, MD, FACMG

President-Elect

2026 – 2028

Sarah H. Elsea, PhD, FACMG

Treasurer

2025 – 2028

Madhuri Hegde, PhD, FACMG

Secretary

2023 – 2027

Sucheta D. Bhatt, MD, FACMG

Director

2025 – 2027

Marilyn C. Jones, MD, FACMG

Director

2024 – 2028

James Lu

Director

2025 – 2027

Rong Mao, MD, FACMG

Director

2023 – 2027

Katie Johansen Taber, PhD

Director

2024 – 2028

David Tilstra, MD, MBA, FACMG

Director

2019 – 2028

Mira B. Irons, MD, FACMG

Ex-Officio Representative

2023 – 2027

Susan D. Klugman, MD, FACMG

Ex-Officio Representative

2021 – 2027

Christa L. Lese Martin, PhD, FACMG

Ex-Officio Representative

2025 – 2027

Melissa T. Forburger, CAE, SHRM-CP

Interim Chief Executive Officer

2025 – 2026

ACMGF President
Brynn Levy

Professor Brynn Levy, MSc(Med), PhD, FACMG

President, ACMG Foundation

Brynn Levy, M.Sc.(Med)., Ph.D., FACMG, is a Professor of Pathology and Cell Biology at the Columbia University Vagelos College of Physicians and Surgeons. He is also the Medical Director of the Clinical Cytogenetics Laboratory of New York-Presbyterian and a Co-Director of the Laboratory of Personalized Genomic Medicine in the Department of Pathology & Cell Biology at Columbia University. He is an early adopter of new technologies for both clinical and research purposes and actively works with groups like the American College of Medical Genetics (ACMG), College of American Pathologists (CAP), Cancer Genomics Consortium (CGC), and the International Society for Prenatal Diagnosis (ISPD) to establish national and international standards and guidelines for integration of new technologies for clinical use.

Dr. Levy recently served as the Genetics and Genomics Section Editor for the journal Prenatal Diagnosis and currently serves on multiple ACMG, CAP, and ClinGen committees. He is the current President of the ACMG Foundation and a past President and one of the founding Board members of the CGC. He also serves on the Board of Directors for the ISPD. He has over 200 peer-reviewed publications, book chapters and presentations and is actively involved in shaping the direction and professional activities of the field of clinical genetics and laboratory diagnostics.

Interim Chief Executive Officer
Melissa T. Forburger

Melissa T. Forburger, CAE, SHRM-CP

Interim Chief Executive Officer

7101 Wisconsin Avenue, Suite 990, Bethesda, MD 20814
301-718-9603

[email protected]

Melissa T. Forburger, CAE, SHRM-CP, is a seasoned nonprofit association executive with more than 30 years’ experience leading organizational operations, optimizing governance, and delivering value to mission-driven membership organizations. Recognized for her collaborative approach, Melissa has dedicated her career to enhancing organizational performance and supporting the professional needs of nonprofit associations. Her comprehensive background spans membership engagement, volunteer management, strategic planning, financial management, human resource management, and operational excellence.

Stepping in as Interim CEO in 2025 was a natural fit for Melissa, who previously served the College for nearly a decade, including in a senior leadership capacity as the Director of Administration where she oversaw strategic initiatives, program development, and cross-departmental operations. Her long-standing familiarity with ACMG’s mission, culture, and membership makes her exceptionally well-positioned to guide the organization through this period of transition.

Melissa has held key leadership roles focused on organizational effectiveness, strategic planning, and program management. Throughout her career, both within ACMG and externally, she has been recognized for fostering collaboration, strengthening internal processes, and aligning complex programs with organizational goals.

In her interim role, Melissa will oversee daily operations and work closely with ACMG and Foundation leadership and staff to ensure continuity across all programs, member services, strategic initiatives, and partnerships.

Melissa and her husband Dave live in the DC suburbs with their three (almost) grown children and loveable labradoodle Archie.

Staff

Melissa T. Forburger, CAE, SHRM-CP

Interim Chief Executive Officer

Alexis Morgan, MPH

Chief Operating Officer

Nataly Schwartz, MBA

Senior Foundation Manager

Judy F. Worthy, MBA

Director of Communications and Public Relations